Publications

The antidepressant-like and glioprotective effects of the Y2 receptor antagonist SF-11 in the astroglial degeneration model of depression in rats: Involvement of glutamatergic inhibition. Helena Domin, Jolanta Konieczny, Paulina Cieślik, Bartłomiej Pochwat, Elżbieta Wyska, Małgorzata Szafarz, Tomasz Lenda, Dominika Biała, Łukasz Gąsior, Maria Śmiałowska, Bernadeta Szewczyk
,
PMID:37871655
Monday, 30 November -0001
Cyclooxygenase-2 inhibition affects the ratio of GluN2A/GluN2B receptor subunits through interaction with mGluR5 in the mouse brain. Katarzyna Stachowicz, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Szymon Rzeźniczek, Magdalena Sowa-Kućma
,
PMID:38244260
Monday, 30 November -0001
Editorial: The pharmacotherapy of depression-searching for new mechanisms and drug interactions. Basic and clinical research, volume II. Katarzyna Stachowicz, Magdalena Sowa-Kućma, Anna Tabecka-Łonczyńska
,
PMID:38595922
Monday, 30 November -0001
Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling. Katarzyna Stachowicz
,
PMID:37898448
Monday, 30 November -0001
The Importance of α-Klotho in Depression and Cognitive Impairment and Its Connection to Glutamate Neurotransmission-An Up-to-Date Review. Patrycja Pańczyszyn-Trzewik, Ewelina Czechowska, Katarzyna Stachowicz, Magdalena Sowa-Kućma
,
PMID:37894946
Monday, 30 November -0001
Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs. Katarzyna Stachowicz
,
PMID:38941064
Monday, 30 November -0001